Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: Q4Q7F6
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 5 |
GO:0006259 | DNA metabolic process | 4 | 5 |
GO:0006308 | DNA catabolic process | 5 | 5 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 5 |
GO:0006807 | nitrogen compound metabolic process | 2 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0009056 | catabolic process | 2 | 5 |
GO:0009057 | macromolecule catabolic process | 4 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0019439 | aromatic compound catabolic process | 4 | 5 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 5 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 5 |
GO:0043170 | macromolecule metabolic process | 3 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044248 | cellular catabolic process | 3 | 5 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 5 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 5 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 5 |
GO:0046483 | heterocycle metabolic process | 3 | 5 |
GO:0046700 | heterocycle catabolic process | 4 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090304 | nucleic acid metabolic process | 4 | 5 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 5 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 5 |
GO:1901575 | organic substance catabolic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 5 |
GO:0003824 | catalytic activity | 1 | 5 |
GO:0004518 | nuclease activity | 4 | 5 |
GO:0004519 | endonuclease activity | 5 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016787 | hydrolase activity | 2 | 5 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0097159 | organic cyclic compound binding | 2 | 5 |
GO:1901363 | heterocyclic compound binding | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 121 | 125 | PF00656 | 0.675 |
CLV_PCSK_FUR_1 | 129 | 133 | PF00082 | 0.483 |
CLV_PCSK_FUR_1 | 170 | 174 | PF00082 | 0.623 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.624 |
CLV_PCSK_PC1ET2_1 | 131 | 133 | PF00082 | 0.483 |
CLV_PCSK_PC1ET2_1 | 172 | 174 | PF00082 | 0.624 |
CLV_PCSK_SKI1_1 | 69 | 73 | PF00082 | 0.600 |
DEG_SCF_FBW7_1 | 114 | 121 | PF00400 | 0.675 |
DOC_AGCK_PIF_2 | 54 | 59 | PF00069 | 0.583 |
DOC_MAPK_gen_1 | 26 | 35 | PF00069 | 0.436 |
DOC_MAPK_MEF2A_6 | 28 | 37 | PF00069 | 0.416 |
DOC_WW_Pin1_4 | 114 | 119 | PF00397 | 0.683 |
LIG_14-3-3_CanoR_1 | 137 | 141 | PF00244 | 0.683 |
LIG_14-3-3_CanoR_1 | 28 | 37 | PF00244 | 0.298 |
LIG_14-3-3_CterR_2 | 170 | 175 | PF00244 | 0.828 |
LIG_APCC_ABBA_1 | 98 | 103 | PF00400 | 0.683 |
LIG_BRCT_BRCA1_1 | 103 | 107 | PF00533 | 0.683 |
LIG_BRCT_BRCA1_1 | 16 | 20 | PF00533 | 0.298 |
LIG_eIF4E_1 | 143 | 149 | PF01652 | 0.683 |
LIG_FHA_2 | 119 | 125 | PF00498 | 0.675 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.683 |
LIG_FHA_2 | 91 | 97 | PF00498 | 0.595 |
LIG_LIR_Apic_2 | 83 | 88 | PF02991 | 0.683 |
LIG_LIR_Gen_1 | 31 | 42 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 55 | 62 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 111 | 116 | PF02991 | 0.683 |
LIG_LIR_Nem_3 | 31 | 37 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.425 |
LIG_LYPXL_yS_3 | 113 | 116 | PF13949 | 0.683 |
LIG_NRBOX | 144 | 150 | PF00104 | 0.683 |
LIG_Pex14_2 | 50 | 54 | PF04695 | 0.583 |
LIG_Pex14_2 | 68 | 72 | PF04695 | 0.583 |
LIG_SH2_CRK | 57 | 61 | PF00017 | 0.458 |
LIG_SH2_NCK_1 | 30 | 34 | PF00017 | 0.488 |
LIG_SH2_PTP2 | 34 | 37 | PF00017 | 0.459 |
LIG_SH2_PTP2 | 40 | 43 | PF00017 | 0.510 |
LIG_SH2_SRC | 34 | 37 | PF00017 | 0.454 |
LIG_SH2_SRC | 40 | 43 | PF00017 | 0.447 |
LIG_SH2_STAP1 | 30 | 34 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.683 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.683 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.588 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.683 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.770 |
LIG_SUMO_SIM_anti_2 | 93 | 99 | PF11976 | 0.683 |
LIG_SUMO_SIM_par_1 | 96 | 104 | PF11976 | 0.683 |
LIG_TYR_ITSM | 109 | 116 | PF00017 | 0.683 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.648 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.683 |
MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.495 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.583 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.675 |
MOD_N-GLC_1 | 109 | 114 | PF02516 | 0.483 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.675 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.683 |
MOD_PKB_1 | 26 | 34 | PF00069 | 0.298 |
MOD_Plk_1 | 101 | 107 | PF00069 | 0.683 |
MOD_Plk_1 | 109 | 115 | PF00069 | 0.583 |
MOD_Plk_1 | 159 | 165 | PF00069 | 0.770 |
MOD_Plk_2-3 | 159 | 165 | PF00069 | 0.770 |
MOD_Plk_2-3 | 83 | 89 | PF00069 | 0.683 |
MOD_ProDKin_1 | 114 | 120 | PF00069 | 0.683 |
TRG_DiLeu_BaLyEn_6 | 77 | 82 | PF01217 | 0.683 |
TRG_ENDOCYTIC_2 | 113 | 116 | PF00928 | 0.683 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.568 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.418 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.269 |
TRG_ER_diArg_1 | 26 | 29 | PF00400 | 0.298 |
TRG_NES_CRM1_1 | 89 | 103 | PF08389 | 0.683 |
TRG_Pf-PMV_PEXEL_1 | 92 | 96 | PF00026 | 0.483 |